Silo Pharma expects about $815,000 for company costs, but sold shares and warrants that can create more shares. That can shrink existing owners' portions, making the deal unfavorable for them.
The cash can help pay day-to-day costs. But the warrants can turn into more shares, leaving each existing owner with a smaller part of Silo. The filing reports no business gain to balance that cost.
Follow Silo Pharma, Inc. (SILO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SILO